Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mohammad Yassin Zamanian"'
Autor:
Mohammad Allahtavakoli, Zahra Kamiab, Mohammad Yassin Zamanian, Małgorzata Kujawska, Mohammad Taher Boroushaki, Mohammad Reza Rahmani, Mohammadreza Gholamrezapour, Fatemeh Pakvojoud, Gholamreza Bazmandegan
Publikováno v:
Caspian Journal of Neurological Sciences, Vol 9, Iss 2, Pp 61-70 (2023)
Background: Inflammation plays a major part in brain ischemia. Propolis is a polyphenol-rich hive product with a set of pharmaceutical properties. Objectives: This research aims to investigate the impact of water extracts of brown propolis (WEPs) on
Externí odkaz:
https://doaj.org/article/8a3ab7ccd0c64b248853db1dbc261f2e
Autor:
Mohammad Yassin Zamanian, Niloofar Taheri, Maria Jade Catalan Opulencia, Dmitry Olegovich Bokov, Sharif Y. Abdullaev, Mohammadreza Gholamrezapour, Mahsa Heidari, Gholamreza Bazmandegan
Publikováno v:
Mediators of Inflammation, Vol 2022 (2022)
Traumatic brain injury (TBI) is still a major cause of concern for public health, and out of all the trauma-related injuries, it makes the highest contribution to death and disability worldwide. Patients of TBI continue to suffer from brain injury th
Externí odkaz:
https://doaj.org/article/dc2e7502ec5843bb9774a846fe6ecdc9
Autor:
Mohammad Reza Rahmani, Mohammad Yassin Zamanian, Mahdi Najafiani Karimvandi, Marjan Nikbakhtzadeh, Elham Zahedi, Dmitry Olegovich Bokov, Małgorzata Kujawska, Mahsa Heidari
Publikováno v:
Current Molecular Pharmacology. 16:507-516
Abstract: Modafinil (MOD, 2‐diphenyl‐methyl‐sulphinil‐2‐acetamide) is a stimulant-like medicine used to treat narcolepsy. Off-label uses include improving cognitive ability in the course of other diseases. This review aims to discuss findin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d912e6062eca124f8a981b3a03e88c
https://doi.org/10.2174/1874467215666220901122824
https://doi.org/10.2174/1874467215666220901122824
Autor:
Elham Hakimizadeh, Mohammad Yassin Zamanian, Vitaliy Viktorovich Borisov, Lydia Giménez‐Llort, Vahid Ehsani, Ayat Kaeidi, Jalal Hassanshahi, Fatemeh Khajehasani, Sajjadeh Movahedinia, Iman Fatemi
Publikováno v:
Fundamental & Clinical Pharmacology. 36:501-508
Gemfibrozil (GFZ) is a lipid-lowering drug with several other effects, such as antioxidant and anti-inflammatory activities. In the current study, chronic d-galactose treatment (d-gal, 150 mg/kg/day; i.p., 6 weeks) induced a model of accelerated agin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d977247a5dbb031904de2ac4af4f94cd
https://doi.org/10.1111/fcp.12752
https://doi.org/10.1111/fcp.12752
Autor:
Amin Hassanshahi, Soudeh Ramezanpour, Zahra Kamiab, Mohammad Yassin Zamanian, Małgorzata Kujawska, Marjan Nikbakht Zadeh, Gholamreza Bazmandegan
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 20:942-953
Background & Objective: Neurological diseases are becoming a significant problem worldwide, with the elderly at a higher risk of being affected. Several researchers have investigated the neuroprotective effects of Carvacrol (CAR) (5-isopropyl-2-methy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f141d48a37f086e101176b377354e06f
https://doi.org/10.2174/1871527320666210506185042
https://doi.org/10.2174/1871527320666210506185042
Autor:
Samira Alesaeidi, Mohammad Yassin Zamanian, Ermias Mergia Terefe, Niloofar Taheri, Małgorzata Kujawska, Yekta Jahedi Tork, Walid Kamal Abdelbasset, Shehla Shoukat, Maria Jade Catalan Opulencia, Mahsa Heidari
Publikováno v:
CNSneurological disorders drug targets.
Abstract: Parkinson's disease [PD] is a chronic and progressive neurological disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta [SNc]. The pathogenesis of PD is strongly related with mitochondrial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac3248d83ca1a070b819549165a443a
https://pubmed.ncbi.nlm.nih.gov/36200161
https://pubmed.ncbi.nlm.nih.gov/36200161
Autor:
Gholamreza Bazmandegan, Mohammad Yassin Zamanian, Lydia Giménez-Llort, Marjan Nikbakhtzadeh, Zahra Kamiab, Mahsa Heidari
Publikováno v:
Current molecular pharmacology.
Abstract: In the present study, the health-protective and therapeutic properties of MET have been discussed, focusing on the effect of MET on the Nrf2 expression in patients with different pathological conditions. Metformin (MET) regulates high blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b77abada6d79e521f31abd8510caa04e
https://pubmed.ncbi.nlm.nih.gov/35726417
https://pubmed.ncbi.nlm.nih.gov/35726417
Publikováno v:
Fundamentalclinical pharmacologyREFERENCES. 36(3)
Being the most essential organ in the body, the liver performs critical functions. Hepatic disorders, such as alcoholic liver disease, hepatic steatosis, liver fibrosis, nonalcoholic fatty liver disease, hepatocellular carcinoma, and hepatic failure,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49f397bc68817047a5ee7ce8b125b97
https://pubmed.ncbi.nlm.nih.gov/34935193
https://pubmed.ncbi.nlm.nih.gov/34935193
Autor:
Elham Hakimizadeh, Mohammad Yassin Zamanian, Morteza Damankhorshid, Lydia Giménez‐Llort, Clara Sciorati, Marjan Nikbakhtzadeh, Khadijeh Moradbeygi, Małgorzata Kujawska, Ayat Kaeidi, Zahra Taghipour, Iman Fatemi
Publikováno v:
Fundamentalclinical pharmacologyREFERENCES. 36(4)
Calcium dobesilate (CaD) is used for the treatment of diabetic retinopathy and nephropathy. This agent exerts antioxidant effects. In the present study, we evaluated the protective effects of oral administration of CaD against hepatorenal damages in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a566339bcf80af1b791c38b160d587
https://pubmed.ncbi.nlm.nih.gov/35112398
https://pubmed.ncbi.nlm.nih.gov/35112398